DK1680128T3 - Myo-inositolhexaphosphat til topisk anvendelse - Google Patents
Myo-inositolhexaphosphat til topisk anvendelseInfo
- Publication number
- DK1680128T3 DK1680128T3 DK04798764T DK04798764T DK1680128T3 DK 1680128 T3 DK1680128 T3 DK 1680128T3 DK 04798764 T DK04798764 T DK 04798764T DK 04798764 T DK04798764 T DK 04798764T DK 1680128 T3 DK1680128 T3 DK 1680128T3
- Authority
- DK
- Denmark
- Prior art keywords
- myo
- inositol hexaphosphate
- topical use
- development
- treatment
- Prior art date
Links
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Diphosphoinositol tetrakisphosphate Chemical compound OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 title abstract 4
- 230000000699 topical effect Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 210000004872 soft tissue Anatomy 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200302600A ES2232302B1 (es) | 2003-11-07 | 2003-11-07 | Myo-inositol hexafosfato para uso topico. |
PCT/IB2004/003588 WO2005044278A1 (fr) | 2003-11-07 | 2004-11-03 | Hexaphosphate de myo-inositol pour usage topique |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1680128T3 true DK1680128T3 (da) | 2007-06-11 |
Family
ID=34566008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04798764T DK1680128T3 (da) | 2003-11-07 | 2004-11-03 | Myo-inositolhexaphosphat til topisk anvendelse |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070066574A1 (fr) |
EP (1) | EP1680128B1 (fr) |
JP (1) | JP4786543B2 (fr) |
AT (1) | ATE353655T1 (fr) |
BR (1) | BRPI0415713A (fr) |
CA (1) | CA2544963C (fr) |
CY (1) | CY1106574T1 (fr) |
DE (1) | DE602004004817T2 (fr) |
DK (1) | DK1680128T3 (fr) |
ES (2) | ES2232302B1 (fr) |
MX (1) | MXPA06005043A (fr) |
PL (1) | PL1680128T3 (fr) |
PT (1) | PT1680128E (fr) |
SI (1) | SI1680128T1 (fr) |
WO (1) | WO2005044278A1 (fr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2828206B1 (fr) * | 2001-08-03 | 2004-09-24 | Centre Nat Rech Scient | Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire |
CA2488230C (fr) * | 2002-04-29 | 2013-04-09 | Yves Claude Nicolau | Inositol pyrophosphates et procede d'utilisation desdits composes |
US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
US20060106000A1 (en) * | 2004-07-06 | 2006-05-18 | Claude Nicolau | Use of inositol-tripyrophosphate in treating tumors and diseases |
US7745423B2 (en) * | 2004-07-06 | 2010-06-29 | NormOxys, Inc | Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin |
US20060258626A1 (en) * | 2004-07-06 | 2006-11-16 | Claude Nicolau | Use of inositol-tripyrophosphate in treating tumors and diseases |
WO2006102060A1 (fr) * | 2005-03-18 | 2006-09-28 | Oxyplus, Inc. | Sel de calcium de myo-inositol 1,6:2,3:4,5 tripyrophosphate utile comme effecteur allosterique de l'hemoglobine |
ES2272191B1 (es) * | 2005-10-14 | 2008-04-01 | Universitat De Les Illes Balears | Utilizacion del fitato para el tratamiento del agua. |
ES2280136B1 (es) * | 2006-02-17 | 2008-08-16 | Universitat De Les Illes Balears | Asociacion a dosis fija de fitato y zinc. |
ES2288126B2 (es) * | 2006-06-01 | 2009-07-06 | Universitat De Les Illes Balears | Utilizacion de fitato como agente inhibidor de la disolucion de cristales de sales calcicas para la prevencion o tratamiento de la osteoporosis. |
CN101784193A (zh) * | 2007-05-01 | 2010-07-21 | 诺尔姆奥克西斯公司 | 促红细胞生成素互补或替代 |
ES2332636B1 (es) * | 2008-08-06 | 2011-02-10 | Universitat De Les Illes Balears | Composicion de liquido de dialisis. |
US9364490B2 (en) | 2013-03-15 | 2016-06-14 | Laboratoris Sanifit, S.L. | Use of derivatives containing C—O—P bonds in patients with kidney failure |
ES2495666B1 (es) * | 2013-03-15 | 2015-08-10 | Laboratoris Sanifit, S.L. | Uso de derivados con enlaces c-o-p en pacientes con fallo renal |
DE102016013737A1 (de) | 2016-11-17 | 2018-05-17 | WindplusSonne GmbH | Hexahydroxycyclohexanhexaphosphorsäureestersalze zur Behandlung von Kalzinose sowie diätische Lebensmittel mit Hexahydroxycyclohexanhexaphosphorsäureestersalzen als Zusatzstoffe |
WO2019176693A1 (fr) * | 2018-03-15 | 2019-09-19 | 国立大学法人広島大学 | Inhibiteur de l'expression du facteur lié à la formation osseuse ou au facteur lié à la calcification dans un tissu extrasquelettique |
MX2021003653A (es) * | 2018-10-11 | 2021-06-23 | Sanifit Therapeutics S A | Inositol fosfatos para el tratamiento de calcificacion ectopica. |
JP2022521119A (ja) | 2019-01-30 | 2022-04-06 | サニフィット・セラピューティクス・ソシエダッド・アノニマ | 組織の灌流の増加における使用のためのイノシトールリン酸化合物 |
EP3818983A1 (fr) | 2019-11-11 | 2021-05-12 | Sanifit Therapeutics S.A. | Composés de phosphate d'inositol pour une utilisation dans le traitement, l'inhibition de la progression ou la prévention de la calcification cardiovasculaire |
EP4015494A1 (fr) | 2020-12-15 | 2022-06-22 | Sanifit Therapeutics S.A. | Procédés de préparation de sels solubles de phosphates d'inositol |
EP4036097A1 (fr) | 2021-01-29 | 2022-08-03 | Sanifit Therapeutics S.A. | Composés dérivés substitués de l'ip4-4,6 |
TW202412815A (zh) | 2022-07-29 | 2024-04-01 | 西班牙商薩尼菲特治療公司 | Ip5經取代化合物 |
WO2024023359A1 (fr) | 2022-07-29 | 2024-02-01 | Sanifit Therapeutics, S.A. | Composés dérivés substitués en ip4-4,6 destinés à être utilisés dans le traitement, l'inhibition de la progression et la prévention de la calcification ectopique |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3934002A (en) * | 1972-06-30 | 1976-01-20 | The Procter & Gamble Company | Oral compositions for plaque, caries and calculus retardation with reduced staining tendencies |
JPH01305033A (ja) * | 1988-06-01 | 1989-12-08 | Sanwa Kagaku Kenkyusho Co Ltd | 循環改善剤及び循環改善機能性食品並びにし好品 |
US5082833A (en) * | 1988-06-30 | 1992-01-21 | Shamsuddin Abulkalam M | Reduction of cell proliferation and enhancement of nk-cell activity |
US5268176A (en) * | 1991-07-22 | 1993-12-07 | Avon Products, Inc. | Method and compositions for the non-invasive treatment of telangiectasia |
US5516801A (en) * | 1992-08-21 | 1996-05-14 | Scotia Holdings Plc | Fatty acid treatment for ectopic calcium deposition |
DE4444238A1 (de) * | 1994-12-13 | 1996-06-20 | Beiersdorf Ag | Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden |
US6359194B1 (en) * | 1995-02-10 | 2002-03-19 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the treatment and diagnosis of cardiovascular disease |
US5536499A (en) * | 1995-02-24 | 1996-07-16 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Cosmetic compositions for reducing or preventing signs of cellulite |
US5821237A (en) * | 1995-06-07 | 1998-10-13 | The Procter & Gamble Company | Compositions for visually improving skin |
US5614511A (en) * | 1996-03-11 | 1997-03-25 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Cosmetic compositions for treating itchy skin |
JP3623430B2 (ja) * | 2000-07-06 | 2005-02-23 | 築野ライスファインケミカルズ株式会社 | 抗酸化性組成物 |
JP2003238414A (ja) * | 2001-12-13 | 2003-08-27 | Sangaku Renkei Kiko Kyushu:Kk | 医薬組成物 |
EP1327443A1 (fr) * | 2001-12-21 | 2003-07-16 | Kyowa Hakko Kogyo Co., Ltd. | Agents pour traitement ou prévention des maladies causées par une réduction de l'expression de la protéine klotho |
-
2003
- 2003-11-07 ES ES200302600A patent/ES2232302B1/es not_active Expired - Fee Related
-
2004
- 2004-11-03 MX MXPA06005043A patent/MXPA06005043A/es active IP Right Grant
- 2004-11-03 US US10/595,709 patent/US20070066574A1/en not_active Abandoned
- 2004-11-03 DK DK04798764T patent/DK1680128T3/da active
- 2004-11-03 AT AT04798764T patent/ATE353655T1/de active
- 2004-11-03 PL PL04798764T patent/PL1680128T3/pl unknown
- 2004-11-03 SI SI200430274T patent/SI1680128T1/sl unknown
- 2004-11-03 EP EP04798764A patent/EP1680128B1/fr active Active
- 2004-11-03 DE DE602004004817T patent/DE602004004817T2/de active Active
- 2004-11-03 CA CA2544963A patent/CA2544963C/fr not_active Expired - Fee Related
- 2004-11-03 BR BRPI0415713-3A patent/BRPI0415713A/pt not_active IP Right Cessation
- 2004-11-03 WO PCT/IB2004/003588 patent/WO2005044278A1/fr active IP Right Grant
- 2004-11-03 ES ES04798764T patent/ES2282920T3/es active Active
- 2004-11-03 PT PT04798764T patent/PT1680128E/pt unknown
- 2004-11-03 JP JP2006538978A patent/JP4786543B2/ja not_active Expired - Fee Related
-
2007
- 2007-05-10 CY CY20071100626T patent/CY1106574T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2544963C (fr) | 2010-03-30 |
ATE353655T1 (de) | 2007-03-15 |
EP1680128A1 (fr) | 2006-07-19 |
US20070066574A1 (en) | 2007-03-22 |
ES2232302B1 (es) | 2006-08-01 |
JP4786543B2 (ja) | 2011-10-05 |
ES2232302A1 (es) | 2005-05-16 |
PL1680128T3 (pl) | 2007-07-31 |
MXPA06005043A (es) | 2007-03-15 |
DE602004004817D1 (de) | 2007-03-29 |
CA2544963A1 (fr) | 2005-05-19 |
PT1680128E (pt) | 2007-05-31 |
WO2005044278A1 (fr) | 2005-05-19 |
SI1680128T1 (sl) | 2007-08-31 |
EP1680128B1 (fr) | 2007-02-14 |
DE602004004817T2 (de) | 2007-11-22 |
CY1106574T1 (el) | 2012-01-25 |
JP2007510710A (ja) | 2007-04-26 |
BRPI0415713A (pt) | 2006-12-19 |
ES2282920T3 (es) | 2007-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1680128T3 (da) | Myo-inositolhexaphosphat til topisk anvendelse | |
MXPA05011208A (es) | Uso de ivermectina para el tratamiento de desordenes dermatologicos. | |
NO20064186L (no) | Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod | |
AR047841A1 (es) | Metodos y composiciones para el tratamiento de transtornos inmunoinflamatorios | |
CR9949A (es) | Inhibidores de proteina activadora de la 5-lipoxigenasa (flap) | |
ATE355065T1 (de) | Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika | |
BR0312573A (pt) | Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina | |
NO20064041L (no) | Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter | |
ATE534378T1 (de) | Titrierung von tapentadol | |
WO2009002867A3 (fr) | Forme posologique à unités multiples contenant un agent thérapeutique en combinaison avec un complément alimentaire | |
BRPI0509053A (pt) | composição farmacêutica anidra e uso de um agente siliconado e de uma composição | |
DE602006009259D1 (de) | Pharmazeutische zusammensetzung mit einem organopoirkstoff | |
EA200702336A1 (ru) | ПРИМЕНЕНИЕ 24-норУДХК | |
ECSP077843A (es) | Tratamiento o prevención del prurito | |
EA200970353A1 (ru) | Комбинированное лекарственное средство | |
BRPI0611526A2 (pt) | composição tópica contendo gelatina | |
DE602005010844D1 (de) | Pharmazeutische zusammensetzungen mit interferon-tau | |
BRPI0512316A (pt) | métodos para prevenir ou atenuar uma ou mais complicações da hemorragia intracerebral e para prevenir ou atenuar uma ou mais complicações da ich em uma maioria de pacientes com ich, e, uso de um primeiro agente de coagulação | |
PT1220676E (pt) | Prevencao do cancro colorrectal | |
EA200801890A1 (ru) | Средство для лечения шума в ушах | |
DK1675611T3 (da) | Terapeutiske anvendelser for C-peptid | |
CR8584A (es) | Piperazinas derivadas de urea para el tratamiento de la endometrosis | |
ATE484288T1 (de) | Pharmazeutische zusammensetzungen zur linderung von übermässig hohen zuckerspiegeln bei diabetikern | |
ATE357220T1 (de) | Pharmazeutische zusammensetzung mit modifizierter freisetzung | |
BRPI0510503A (pt) | compostos e composições como inibidores de catepsina s |